{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"AI shortens drug discovery to around 1 year in China: Insilico CEO","author_name":"techandbusiness.org · AI","thumbnail_url":"https://techandbusiness.org/api/og/newswire/wBqNcnjvGrQ0XrF-iQBqkR","thumbnail_width":1200,"thumbnail_height":630,"width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · AI</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/wBqNcnjvGrQ0XrF-iQBqkR\" style=\"color:#fff;text-decoration:none;\">AI shortens drug discovery to around 1 year in China: Insilico CEO</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said.\n\nInsilico CEO Alex Zhavoronkov told Reuters in ...</p>\n    </blockquote>"}